MoonLake Immunotherapeutics (MLTX) Q2 2026 Earnings

7MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-1.1
-0.98
-0.86
-0.74

Details

Expected EPS
-0.908
Actual EPS
N/A
Surprise EPS
0.91
Surprise Percent
+100%

Description

MoonLake Immunotherapeutics (MLTX) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts